Riskpilot← Back to searchSign inGet full accessMedverka AB
ABActiveOrg 5569318396Gustav Iii:S Boulevard 11Computer consultancy and computer facilities management activities · NACE 6220Est. 20131 employees
Revenue 2025
SEK 0
EBITDA margin
—
0% vs 2024
Equity ratio
95.9%
Financial strength
Net profit 2025
SEK -25K
-112% vs 2024
| Revenue | SEK 0 | — |
| EBITDA | SEK -250K | +0% |
| Net profit | SEK -25K | -112% |
| Total assets | SEK 1,1M | -18% |
| Equity | SEK 1M | -19% |
| Employees | 1 | — |
Legal name
Medverka AB
Org number
5569318396
Legal form
Aktiebolag
NACE code
6220 · Computer consultancy and computer facilities management activities
Founded
15 maj 2013
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska bedriva konsultverksamhet inom management, konsultverksamhet avseende utvecklingsmodeller samt metod och teknikstöd, konsultverksamhet, förmedling och utveckling av datasystem, företrädesvis avseende mjukvara, utbildningsverksamhet samt handel med fast egendom och värdepapper ävensom idka därmed förenlig verksamhet.
Address
Gustav Iii:S Boulevard 11
Email
staffan.wessman@medverka.nu
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 25 | 0 | 0 | 0 | 0 |
| Staff expenses | — | −338 | −284 | −189 | −200 |
| EBITDA | −342 | −388 | −335 | −251 | −250 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | −342 | −388 | −335 | −251 | −250 |
| Net financials | 353 | 30 | 15 | 457 | 225 |
| Profit before tax | 99 | −0 | −182 | 206 | −25 |
| Tax | −0 | — | — | — | — |
| Net profit | 99 | −0 | −182 | 206 | −25 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 2 377 | 1 836 | 1 313 | 1 303 | 1 069 |
| Equity | 1 822 | 1 634 | 1 257 | 1 259 | 1 025 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 59 | 64 | 56 | 43 | 44 |
| Total debt | 59 | 64 | 56 | 43 | 44 |
EBITDA margin
-24992600.0%
This company
15.8%
Market median
-158181113% vs market
20212025
Equity ratio
95.9%
This company
38.2%
Market median
+151% vs market
20212025
Return on equity
-2.4%
This company
18.4%
Market median
-113% vs market
20212025
Net profit margin
-2452500.0%
This company
8.1%
Market median
-30277878% vs market
20212025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212025
Debt / equity
0.04×
This company
0.62×
Market median
+94% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Medverka AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Åsa Björnsdotter Lovén | Deputy Board Member | 0 companies |
| Carl Staffan Wessman | Board of Directors | 0 companies |